ASB Consultores’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $382K | Sell |
490
-59
| -11% | -$46K | 0.26% | 69 |
|
|
2025
Q1 | $453K | Sell |
549
-275
| -33% | -$227K | 0.29% | 48 |
|
|
2024
Q4 | $636K | Sell |
824
-301
| -27% | -$232K | 0.26% | 59 |
|
|
2024
Q3 | $997K | Sell |
1,125
-20
| -2% | -$17.7K | 0.39% | 37 |
|
|
2024
Q2 | $1.04M | Sell |
1,145
-950
| -45% | -$860K | 0.37% | 30 |
|
|
2024
Q1 | $1.63M | Buy |
2,095
+1,568
| +298% | +$1.22M | 0.42% | 29 |
|
|
2023
Q4 | $307K | Sell |
527
-228
| -30% | -$133K | 0.1% | 69 |
|
|
2023
Q3 | $406K | Sell |
755
-301
| -29% | -$162K | 0.16% | 63 |
|
|
2023
Q2 | $495K | Buy |
1,056
+137
| +15% | +$64.3K | 0.24% | 76 |
|
|
2023
Q1 | $316K | Sell |
919
-52
| -5% | -$17.9K | 0.13% | 124 |
|
|
2022
Q4 | $355K | Buy |
971
+169
| +21% | +$61.8K | 0.15% | 105 |
|
|
2022
Q3 | $259K | Sell |
802
-127
| -14% | -$41K | 0.12% | 134 |
|
|
2022
Q2 | $301K | Sell |
929
-382
| -29% | -$124K | 0.13% | 108 |
|
|
2022
Q1 | $375K | Sell |
1,311
-10
| -0.8% | -$2.86K | 0.16% | 119 |
|
|
2021
Q4 | $365K | Buy |
+1,321
| New | +$365K | 0.18% | 123 |
|